CYPHERPUNK TECHNOLOGIES INC. Shareholders' Equity
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Shareholders' Equity of $139.32 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $139.32M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $84.38M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $153.51M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.69M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $139.32M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $84.38M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $153.51M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $2.69M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.72M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $20.84M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $35.05M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $48.95M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $65.79M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $47.37M 10-Q · filed 2025-08-14 |
| 2023-12-31 | $60.14M 10-K · filed 2026-03-16 |
| 2023-09-30 | $72.01M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $84.06M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $28.33M 10-Q · filed 2024-08-12 |
| 2022-12-31 | $58.87M 10-K · filed 2025-03-26 |
| 2022-09-30 | $70.07M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $83.32M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $98.56M 10-Q · filed 2023-08-14 |
| 2021-12-31 | $107.89M 10-K · filed 2024-03-18 |
| 2021-09-30 | $116.82M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $29.88M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $38.38M 10-Q · filed 2022-08-12 |
| 2020-12-31 | $46.65M 10-K · filed 2023-03-24 |
| 2020-09-30 | $53.14M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $59.73M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $17.96M 10-Q · filed 2021-08-13 |
| 2019-12-31 | -$1.75M 10-K · filed 2022-03-11 |
| 2019-09-30 | $5.56M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $10.94M 10-Q · filed 2020-11-12 |
| 2019-03-31 | $17.06M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $9.18M 10-K · filed 2021-03-12 |
| 2018-09-30 | $6.63M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $12.13M 10-Q · filed 2019-11-14 |
| 2018-03-31 | $16.13M 10-Q · filed 2019-08-09 |
| 2017-12-31 | $11.12M 10-K · filed 2020-03-16 |
| 2017-09-30 | $11.59M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $18.35M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $24.17M 10-Q · filed 2017-05-12 |
| 2016-12-31 | -$100.23M 10-K · filed 2019-04-01 |
| 2015-12-31 | -$70.29M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |